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Abstract Autism spectrum disorder (ASD) and attention-def-
icit/hyperactivity disorder (ADHD) frequently co-occur.
Besides shared genetic factors, pre- and perinatal risk factors
(PPFs) may determine if ASD, ADHD, or the combination of
both disorders becomes manifest. This study aimed to test
shared and unique involvement of PPFs for ASD and
ADHD, using an approach that stratifies the sample into
affected/unaffected offspring and single-incidence (SPX) ver-
sus multi-incidence (MPX) families. Pre- perinatal data based
on retrospective parent-report were collected in 288 children
(71 % males) from 31 SPX and 59 MPX ASD families, 476
children (65 % males) from 31 SPX and 171 MPX ADHD
families, and 408 control children (42 % males). Except for
large family size and more firstborns amongst affected off-
spring, no shared PFFs were identified for ASD and ADHD.
PPFs predominantly related to ASD (maternal infections and
suboptimal condition at birth) were more often reported in
affected than unaffected siblings. PPFs associated with
ADHD (low parental age, maternal diseases, smoking and
stress) were shared between affected and unaffected siblings.
Firstborn-ship was more frequent in SPX than MPX ASD
probands. Our results suggest that the co-morbidity of ASD
and ADHD is not likely explained by shared PPFs. Instead,
PPFs might play a crucial role in the developmental pathways
leading up to either disorder. PPFs in ADHD appear to index
an increased shared risk, whereas in ASD PPFs possibly have
a more determining role in the disorder. SPX-MPX stratifica-
tion detected possible etiological differences in ASD families,
but provided no deeper insight in the role of PPFs in ADHD.
Keywords Autism SpectrumDisorders (ASD) .
Attention-Deficit/Hyperactivity Disorder (ADHD) .
Simplex-multiplex stratification . Prenatal and perinatal risk
factors
Autism spectrum disorder (ASD) and attention deficit/
hyperactivity disorder (ADHD) are both highly heritable,
impairing neurodevelopmental disorders that manifest early
in development and frequently co-occur (Lichtenstein et al.
2010). ASD is characterized by impairments in social interac-
tion, deficits in verbal and non-verbal communication and by
restricted or repetitive patterns of behavior and interests.
ADHD is characterized by symptoms of hyperactivity, impul-
sivity and/or inattention (American Psychiatric Association
2013). High co-morbidity might be explained by shared ge-
netic factors, as indicated by twin studies (Ronald et al. 2008).
However, genetic effects do not account for all phenotypic
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covariation (Ronald et al. 2008), implying that the high co-
morbidity rates of ASD and ADHD might also be explained
by other factors, such as shared pre- and perinatal risk factors
(PPFs) (Rutter and Silberg 2002).
PPFs have proven important in the etiology of both ASD
and ADHD. However, since ASD or ADHD have been stud-
ied mostly in isolation, we have little knowledge about wheth-
er PPFs are shared between the disorders. In meta-analyses of
ASD, advanced parental age at birth, maternal prenatal med-
ication use, gestational bleeding, diabetes, being firstborn, fe-
tal distress, birth injury or trauma, low 5-min APGAR score
and low birth weight (<5.5 lb or 2500 g) were more frequently
observed in individuals with ASD than in controls (Gardener
et al. 2009, 2011). Maternal infections, maternal stress, sub-
optimal condition of the child at birth, prematurity, smoking
during pregnancy (Visser et al. 2013), and a birth weight more
than two standard deviations above average for gestational age
(Abel et al. 2013) were also found related to ASD. Research
on ADHD indicates that prenatal exposure to nicotine, alco-
hol, drugs or toxins, and maternal stress, low birth weight, low
maternal age and poor maternal diet are associated with an
increased likelihood of developing ADHD (Mill and
Petronis 2008; Thapar et al. 2013). Furthermore, an associa-
tion has been reported between neonatal complications and
the severity of ADHD symptoms (Ben Amor et al. 2005).
Only two studies so far investigated which early childhood
indicators (including PPFs) might be shared between ASD
and ADHD, by examining these risk factors in the general
population (Jaspers et al. 2013; St St Pourcain et al. 2011).
St Pourcain et al. found that maternal smoking might be com-
mon to ASD- and ADHD-like symptoms. Jaspers and col-
leagues reported that male gender and low educational level
of the mother were overlapping indicators, yet PPFs such as
maternal smoking and low birth weight were specific for
ADHD and ASD traits, respectively. All considered, these
findings on population-based samples suggest limited overlap
of PPFs in ASD and ADHD, except perhaps for low birth
weight and maternal smoking. The role of shared PPFs might,
however, be different in clinical samples, given greater sever-
ity of clinical symptoms among referred cases. In the current
study that combines two clinical ASD and ADHD cohorts, we
aimed to explore this issue further.
Which role PPFs play in a disorder can be understood by
looking at the prevalence of these risk factors in unaffected
siblings of patients. The advantage of an affected-unaffected
sibling design is that it controls for familial (genetic back-
ground and shared environmental) risk factors (Ben Amor
et al. 2005). When certain PPFs are present in both affected
and unaffected siblings, these factors are probably related to
an overall increased risk of developing the disorder (trait fac-
tors), without a unique, determining contribution to the disor-
der. Vice versa, PPFs (predominantly) found in affected off-
spring but not in unaffected offspring may have a more
penetrant, possibly uniquely determining effect on the devel-
opment of the disorder (state factors). Research comparing
affected and unaffected ASD siblings showed that medication
use during pregnancy, being firstborn, higher non-optimality
scores, low birth weight and low APGAR scores are all rela-
tively more prevalent in autistic children compared to their
unaffected siblings (Deykin and MacMahon 1980), suggest-
ing that these factors may explain why the probands did de-
velop ASD, yet their siblings did not. In ADHD families,
affected children appear to have significantly higher rates of
low birth weight and medical conditions when compared to
unaffected siblings, but intriguingly, smoking and alcohol
consumption during pregnancy do not appear to differ among
siblings (Ben Amor et al. 2005). Recent studies using genet-
ically informative designs suggest the latter factors to be a
proxy of ADHD risk genes passed from mother to offspring,
rather than predominantly environmental toxic factors
(Thapar et al. 2013). The above described research indicates
that there might indeed be specific PPFs that are present in
affected individuals, but also PPFs that are shared by affected
and non-affected (ADHD) siblings. This is the first study to
examine which PPFs are related to ASD and/or ADHD and to
what extend these factors are uniquely present in affected
offspring or shared between affected and unaffected siblings.
A second and more in depth approach that can improve our
understanding of the role of PPFs in ASD and ADHD is to
stratify families into simplex (SPX) or multiplex (MPX) af-
fected ones. Families with only one affected individual are
defined as SPX and families in which two or more individuals
are affected, are defined as MPX. The hypothesis is that the
constellation of etiological factors differs between SPX versus
MPX families. It is expected that individuals from SPX fam-
ilies are more likely than individuals from MPX families to
develop the disorder as a result of sporadic genetic (e.g., de
novo mutations) or non-genetic causes (e.g., rare PPFs with
high penetrance) strictly personal to the patient. These factors
may (at least partly) explain why that child developed ASD or
ADHD, yet his/her siblings did not. In families with multiple
cases of the disorder (MPX families) risk factors may be
shared between affected individuals. Previous molecular ge-
netic studies confirmed the assumption of different etiologies
for SPX and MPX cases, demonstrating that a more than
threefold rate of de novo mutations was identified in ASD
SPX families (~7–10 %), compared to ASD MPX families
(~2–3 %) or control families (~1 %) (Sebat et al. 2007), indic-
ative of an increased incidence of non-heritable, non-shared
risk factors in SPX families. In contrast, it was found that
members of MPX families were often in fact less-affected
family members, more often exhibiting disorder-related be-
havioral symptoms and cognitive deficits compared to mem-
bers of SPX families, indicative of a more pronounced role of
shared genetic predispositions (Gerdts et al. 2013; Oerlemans
et al. 2015a; Oerlemans et al. 2015b; Virkud et al. 2009). No
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studies so far have investigated whether differences exist be-
tween SPX and MPX ASD and ADHD families. It may be
expected that in SPX families, rare, non-shared PPFs with
high penetrance that are unique to the affected child and that
are not present during the pregnancy and birth of the unaffect-
ed siblings are more frequent, whereas common, low pene-
trance PPFs that increase the overall liability for a disorder are
expected to be more frequent in MPX families.
In sum, this is the first study that tests if PPFs for ASD and
ADHD are unique or shared using an approach that stratifies
the sample into affected versus unaffected offspring and SPX
versus MPX-affected families. First, we tested which PPFs
were associated with ASD, ADHD or both. Second, we tested
whether PPFs only present in affected –but not unaffected-
offspring may have a unique, highly penetrant contribution
to the disorder (state factors) instead of increasing the overall
liability for the disorder only slightly (trait factors). Third, we
examined whether offspring fromMPX families shares a large
proportion of PPFs, whereas in SPX families PPFs were most-
ly non-shared between affected and unaffected siblings.
Methods
ASD and ADHD families were recruited as part of two large
family-genetic studies: the Biological Origins of Autism
(BOA) study and the Dutch part of the International
Multicenter ADHD Genetics (IMAGE) study (as described
previously in Oerlemans et al. 2015b). Case families were
recruited through child psychiatric and pediatric clinics and
the Dutch Autism Association (NVA). Families potentially
satisfying inclusion criteria received an information brochure
and, if interested, were asked to return a pre-stamped response
card. Control families were recruited from the same geograph-
ical regions as the participating case families via schools and
information leaflets. Inclusion criteria for all participants were
at least two biological siblings (in case families: at least one
child with a clinical diagnosis of ASD or ADHD) and one
biological parent willing to participate, European Caucasian
descent, offspring age between 4 and 20 years, and offspring
IQ≥70. Children with a diagnosis of epilepsy, brain disorders
or known genetic disorders, such as Down-syndrome or
Fragile-X-syndrome were excluded from participation in or-
der to reduce etiological heterogeneity and provide ASD and
ADHD samples with greater clinical homogeneity.
All children and parents were carefully phenotyped for
ASD and ADHD using validated and standardized question-
naires and diagnostic interviews, including the Autism
Spectrum Quotient (Baron-Cohen et al. 2001), Conners
Rating Scales (Conners 1996; Conners et al. 1998), Autism
Diagnostic Interview-Revised (Le Couteur et al. 2003), and
Parental Account of Childhood Symptoms ADHD subversion
(Taylor et al. 1991). Families were then stratified into SPX and
MPX based on the number of affected individuals. SPX fam-
ilies were required to have a single-affected proband, a mini-
mum of one male sibling and all siblings and parents of the
proband unaffected by ASD or ADHD; MPX families were
required to have two or more affected individuals. SPX-MPX
stratification was made on the basis of the primary clinical
diagnosis of the probands. That is, SPX and MPX ASD fam-
ilies originate from an ASD cohort in which the primary clin-
ical diagnosis of the proband is ASD, SPX and MPX ADHD
families originate from an ADHD cohort in which the primary
clinical diagnosis of the proband is ADHD.
A total of 288 children from ASD families (including: 56
SPX probands, 96 MPX probands, 81 SPX unaffected sib-
lings, and 55 MPX unaffected siblings), 476 children from
ADHD families (including: 31 SPX probands, 270 MPX pro-
bands, 47 SPX unaffected siblings, and 128 MPX unaffected
siblings), and 408 control children were included in this study,
see Table 1 for sample characteristics. For a full description of
phenotyping and family classification, see Oerlemans et al.
(2015b) or Supplemental Table 1.
Pre-and Perinatal Information
Pre- and perinatal information was retrospectively obtained
through a questionnaire filled out by the parents before diag-
nostic assessments. The questionnaire is derived from the
Prechtl optimality scales used by Gillberg and Gillberg
(1983), with addition of relevant items like parental age, in-
toxications and maternal stress. The items were grouped into
PPFs based on related content following the procedures used
successfully in other studies (e.g., Visser et al. 2013), see
Table 2. For each factor, a dichotomous variable was created,
coding 1 if the risk factor was present and 0 indicating absence
of the risk factor. The factor pregnancy after fertility treatment
was added, because children born following assisted repro-
ductive technologies (ARTs) have been found to be at higher
risk of autism than the general population (Zhan et al. 2013).
Further, given that both low and high birth weight and parental
age were found to be associated with adverse outcomes, it was
decided to examine the effect of these categories separately
(Abel et al. 2013).
Procedure
Questionnaires were filled in separately for each child at
home, mostly by the mother of the child. Additional data
collection included demographic information, blood samples
of all family members and neuropsychological data of the
children. The study was approved by the local medical ethics
board, and parents and children (12 years and older) signed for
informed consent.
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Data Analyses
In the BOA (ASD) study, the pre-and perinatal risk factor
questionnaire was part of the standard test protocol and ad-
ministered to all participating families. Missing data for the
ASD study was less than 5 % and was missing at random,
Little’s (1988) MCAR test, χ2 (69)=59.40, p=0.789. The full
pre-and perinatal risk factor questionnaire was only adminis-
tered to about 50 % of the participating ADHD families
(IMAGE study), since it was added to the test protocol at a
later stage. A shorter version of the questionnaire (which did
not include the PFFs miscarriages/bleeding, maternal dis-
eases, maternal infection, labor/parturition, stress during preg-
nancy, suboptimal condition at childbirth, and pregnancy after
fertility treatment,) was later sent to the remaining participat-
ing families. In the IMAGE cohort, data was not missing
completely at random, Little’s (1988) MCAR test, χ2
(144)=176.76, p=0.033. A series of ANOVAs and Chi-
Squared tests revealed that children whose families did and
did not complete the long version of the questionnaire did not
differ on age, sex, estimated TIQ, parent-rated ASD symp-
toms, teacher-rated ADHD symptoms, and proportion SPX
vs. MPX, p-values>0.10. Children who filled in the short
version of the PPF questionnaire had slightly lower parent-
rated ADHD symptoms (M=57.4, SD=15.2), than children
who did complete the long version (M=60.4, SD=15.9), F
(1, 742)=6.19, p=0.009. However, this is likely explained
by the larger proportion of control families within this short
version group (40 %), compared to the long version group
(31 %), χ2 (1, N=743)=5.95, p=0.015. Missing data were
not imputed to prevent spurious associations.
First, to examine which PPFs were associated with ASD,
ADHD or both, Wald chi-square values were calculated using
generalized estimated equations (GEE) with a binary logistic
model, robust estimators, and exchangeable structure for
working correlation matrices. To correct for familial depen-
dency within the data set, family number was used a repeated
measure. Independent variables were type of disorder (ASD
vs. ADHD vs. control) and sex and the two-way interaction
type of disorder*sex. The two-way interaction was dropped
from the model when non-significant. Sex was added to the
model because previous studies reported that pre-/perinatal
complications are more prevalent in boys (Lukkari et al.
2012) and because groups differed in percentage males (see
Table 1). Odds ratios (ORs) and 95 % confidence intervals
(CIs) were calculated, to define small (OR>1.5), medium
(OR>2.5), and large effects (OR>4.3) (Cohen 1988).
Dependent variables were the PPFs described above and sep-
arate analyses were run for each of the dependent variables.
Because siblings were included in this study and only one
child per family can be firstborn, the factor firstborn could
not be compared between ASD vs. ADHD vs. controls.
Instead, family size was examined between disorders. TheTa
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factor firstborn was examined in post hoc analyses described
below.
Second, for all PPFs significantly associated with ei-
ther ASD or ADHD or both post hoc analyses were
conducted to test a) whether the effect was specific to
affected children or shared between affected and unaf-
fected siblings and b) whether the effect was selectively
found in either SPX or MPX families. Similar GEE
analyses were run with independent variables a) diagno-
sis (affected vs. unaffected siblings) and sex or b) type
of family (SPX vs. MPX families) and sex. For the
factor firstborn, mean family size was included as co-
variate to account for the number of children per family.
The post hoc analyses were run separately for ASD and
ADHD cohorts. A False Discovery Rate (FDR) correc-
tion with a q-value setting of 0.05 was applied to con-
trol for multiple testing (Benjamini 2010). Post hoc
power calculations revealed that our study had sufficient
statistical power to medium to large effects, but we
were underpowered to detect small effects, particularly
for affected vs. unaffected and SPX vs. MPX compari-
sons. Because of the small numbers of individuals avail-
able for some of the exposures and the hypothesis-
generating nature of our study, a distinction was made
between significance (i.e., findings that remained signif-
icant after multiple testing), nominal significance (i.e.,
findings that did not remain significant after multiple
testing), and trend-level significance, p<0.10. The latter
two were reported in order to not miss out on possible
relevant findings that can be tested in future studies. All
analyses were carried out in SPSS version 20.
Results
Larger Family Size is a Shared PPF for ASD and ADHD
Table 3 presents the χ2 tests and ORs for the PPFs for
ASD and ADHD families. Multivariate significant and
trend-level multivariate effects were found on six PPFs,
namely family size, low parental age, tobacco use dur-
ing pregnancy, stress during pregnancy, maternal dis-
eases and maternal infections, p-values<0.10. Only one
of these PPFs was significantly associated with both
disorders, namely the factor family size, ASD families
vs. controls: χ2 (1, N=696)=28.54, p<0.001, OR=1.64,
95 % CI 1.37–1.97; ADHD families vs. controls χ2 (1,
N=884)=27.98, p<0.001, OR=1.41, 95 % CI 1.24–
1.61; ASD vs. ADHD families: p=0.084. Case parents
had significantly more children than control families and
this did not differ between ASD and ADHD.
PPFs Uniquely Associated With Either ASD or ADHD
Predominantly associated with ASD were the factors
maternal infections and suboptimal condition at birth,
χ2 (1, N=539)=3.83, p=0.050, OR=3.97, 95 % CI
1.00–15.82, and χ2 (1, N=540) = 3.88, p= 0.049,
Table 2 Pre-and perinatal risk factors
Prenatal Perinatal
1. Parental age at conception 7. Labor/parturition
- low (mothers < 25 years, fathers < 30 years) prolonged parturition (≥24 h), caesarian section, forceps extraction, vacuum
extraction, breech presentation- high (mothers ≥ 35 years, father ≥ 40 years)
2. Miscarriages / bleeding 8. Prematurity (<37 weeks)
miscarriages in history, gestational bleeding
3. Maternal diseases 9. Birth weight
diabetes, (pre-) eclampsia, high blood pressure, severe nausea - low birth weight (<2500 g)
- high birth weight (>4500 g)
4. Maternal infections 10. Suboptimal condition of child at birth
virus, severe infections low APGAR score at 5 min (<8), respiratory distress, faeces in amniotic fluid,
umbilical cord around neck, physical injury
5. Maternal intoxications 11. Family size/Firstborna
- alcohol use during pregnancy
- tobacco use during pregnancy
6. Stress during pregnancy 12. Pregnancy after fertility treatment
severe tensions, concerns about the child
Note. the items underlying the factors are presented in italic. For each item, a dichotomous variable was created, coding ‘1’ if the complication was
present and ‘0’ if the complication was not present. Then, items were grouped into the pre/perinatal factors based on related content. If at least one
complication was present during pregnancy or delivery, ‘1’ was coded on the overlapping factor
a Because siblings were included in this study, we compared mean family size between disorders and examined firstborn-ship in the post hoc analyses only
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Table 3 Comparisons between controls on the one hand and individuals from ASD and ADHD families, stratified into affected vs. unaffected siblings
and SPX vs. MPX families on the other hand
Control
families
ASD families ADHD families Contrasts based on p-values < .05*
Identification of 
PPFs associated 
with ASD and/or 
ADHDa
Further stratification in significantly associated PFFs
Affected vs. unaffected siblings SPX vs. MPX familiesProbands Unaffected 
sibling
Total Probands Unaffected 
sibling
Total
ASD ADHD ASD ADHD
% (n/N) % (n/N) % (n/N) % (n/N) % (n/N) % (n/N) % (n/N) Contr. OR Contr. OR Contr. OR Contr. OR Contr. OR
1. Parental 
age at 
conception
Low
28.4 
(115/405)
SPX
21.4 
(12/55)
19.8 
(16/81)
20.6 
(28/136)
51.6 
(16/31)
46.8
(22/47)
48.7 
(38/78)
ASD=c .80
A=U 1.83 A=U .81 S=M .65 S=M 1.03MPX
30.2 
(29/96)
27.3
(15/55)
29.1 
(44/151)
45.2 
(122/270)
50.8 
(65/128)
47.0 
(187/398)
ADHD>c 2.26
Total 
27.2 
(41/151)
22.8 
(31/136)
25.0 
(72/288)
49.2 
(148/301)
49.7 
(87/175)
47.4 
(225/475)
ADHD>
ASD 2.84
High
18.0 
(73/405)
SPX
16.1   
(9/56)
14.8 
(12/81)
15.3 
(21/137)
6.5
(2/31)
6.4 
(3/47)
6.4 
(5/78)
ASD=c .87
A=U 1.07 A=U 1.20 S=M .66 S=M .57MPX
19.8 
(19/96)
14.5 
(8/55)
17.9 
(27/151)
10.7 
(29/270)
7.8 
(10/128)
9.8 
(39/398)
ADHD<c .45
Total 
18.4 
(28/152)
14.7 
(20/136)
16.7 
(48/288)
10.3 
(31/301)
7.4 
(13/175)
9.3 
(44/475)
ADHD<
ASD .51
2. 
Miscarriages 
/ bleeding
29.6 
(75/253)
SPX
28.6 
(16/56)
30.0 
(24/80)
29.4 
(40/136)
20.0   
(3/15)
15.8 
(3/19)
17.6 
(6/34)
ASD=c 1.01
MPX
37.5 
(36/96)
30.9 
(17/55)
35.1 
(53/151)
29.3 
(43/147)
30.2 
(19/63)
29.5 
(62/210)
ADHD=c .87
Total 
34.2 
(52/152)
30.4 
(41/135)
32.4 
(93/287)
28.4 
(46/162)
26.8 
(22/82)
27.9 
(68/244)
ASD=
ADHD
.86
3.  Maternal 
diseases
26.9 
(68/253)
SPX
35.7 
(20/56)
24.1 
(19/79)
28.9 
(39/135)
40.0 
(6/15)
21.1 
(4/19)
29.4 
(10/34)
ASD=c 1.34
A=U 1.04 A=U 1.07 S=M .96 S=M .70MPX
32.3 
(31/96)
34.5 
(19/55)
33.1 
(50/151)
40.1 
(59/147)
46.0 
(29/63)
41.9 
(88/210)
ADHD>c 1.84
Total 
33.6 
(51/152)
28.4 
(38/134)
31.1 
(89/286)
40.1 
(65/162)
40.2 
(33/82)
40.2 
(98/244)
ASD=
ADHD
1.38
4. Maternal 
infections
1.2 
(3/253)
SPX
3.6 
(2/56)
2.5 
(2/79)
3.0 
(4/135)
0.0
(0/15)
0.0 
(0/19)
0.0 
(0/34)
ASD>c 3.97
A=U 2.72 A=U 2.63 S=M .57 S=M -bMPX
7.3 
(7/96)
1.8 
(1/55)
5.3 
(8/151)
2.1 
(3/144)
1.6 
(1/62)
1.9 
(4/206)
ADHD=c 1.57
Total 5.9 2.2 4.2 1.9 1.2 1.7 ASD=AD .39
(9/152) (3/134) (12/286) (3/159) (1/81) (4/240) HD
5. Maternal 
intoxications
Alcohol
19.7 
(75/381)
SPX
12.5 
(7/56)
12.7 
(10/79)
12.6 
(17/135)
4.0 
(1/25)
5.3 
(2/38)
4.8 
(3/63)
ASD=c .63
MPX
13.7 
(13/95)
9.1 
(5/55)
12.0 
(18/150)
18.8 
(41/218)
17.0 
(18/104)
18.3 
(59/322)
ADHD=c .89
Total 
13.2 
(20/151)
11.2 
(15/134)
12.3 
(35/285)
17.3 
(42/243)
14.1 
(20/142)
16.1 
(62/385)
ASD=AD
HD
1.43
Smoking
12.9 
(49/381)
SPX
10.9 
(6/55)
11.4
(9/79)
11.2 
(15/134)
15.4 
(4/26)
17.9 
(7/39)
16.9 
(11/65)
ASD=c .85
A=U 1.11 A=U 1.18 S=M .75 S=M .73MPX
11.8 
(11/93)
9.1 
(5/55)
10.8 
(16/148)
28.0 
(61/218)
16.3 
(17/104)
24.2 
(78/322)
ADHD>c 2.12
Total 
11.5 
(17/148)
10.4 
(14/134)
11.0 
(31/282)
26.6 
(65/244)
16.8 
(24/143)
23.0 
(89/387)
ADHD>
ASD 2.50
6. Stress 
during 
pregnancy
13.4 
(34/253)
SPX
25.0 
(14/56)
10.1
(8/79)
16.3 
(22/135)
26.7   
(4/15)
10.5  
(2/19)
17.6 
(6/34)
ASD=c 1.31
A>U 2.19 A=U 1.55 S=M 1.04 S<M .50MPX 17.7 
(17/96)
12.7 
(7/55)
15.9 
(24/151)
31.3 
(46/147)
25.4 
(16/63)
25.8 
(62/240)
ADHD>c 2.61
Total 
20.4 
(31/152)
11.2 
(15/134)
16.1 
(46/286)
30.9 
(50/162)
22.0
(18/82)
27.9 
(68/244)
ADHD>
ASD 2.00
7. Labor/
parturition
22.5 
(57/253)
SPX
30.4 
(17/56)
21.3 
(17/80)
25.0 
(34/136)
26.7   
(4/15)
36.8  
(7/19)
32.4 
(11/34)
ASD=c 1.31
MPX
38.5 
(37/96)
18.2 
(10/55)
31.1 
(47/151)
23.3 
(34/146)
19.4 
(12/62)
22.1 
(46/208)
ADHD=c .99
Total 
35.5 
(54/152)
20.0 
(27/135)
28.2 
(81/287)
23.6 
(38/161)
23.5 
(19/81)
23.6 
(57/242)
ASD=
ADHD
.76
SPX
8.9 
(5/56)
8.6 
(7/81)
8.8 
(12/137)
3.8   
(1/26)
15.4 
(6/39)
10.8 
(7/65)
ASD=c 1.16
8. 
Prematurity
6.1 
(23/374)
MPX
9.4 
(9/96)
3.6 
(2/55)
7.3 
(11/151)
5.6 
(12/213)
4.8 
(5/105)
5.3 
(17/318)
ADHD=c .84
Total 
9.2 
(14/152)
6.6 
(9/136)
8.0 
(23/288)
5.4 
(13/239)
7.6 
(11/144)
6.3 
(24/383)
ASD=
ADHD
.72
9. Birth weight
Low
5.8 
(22/380)
SPX
1.8 
(1/56)
7.7 
(6/78)
5.2 
(7/134)
0.0 
(0/26)
12.8 
(5/39)
7.7 
(5/65)
ASD=c .67
MPX
4.5 
(4/88)
3.9
(2/51)
4.3 
(6/139)
2.8 
(6/214)
2.9 
(3/105)
2.8 
(9/319)
ADHD=c .57
Total 
3.5 
(5/144)
6.2
(8/129)
3.7 
(10/273)
2.5 
(6/240)
5.6 
(8/144)
3.6 
(14/384)
ASD=
ADHD
.86
High 2.1 (8/380)
SPX
1.8
(1/56)
7.7
(6/78)
5.2 
(7/134)
3.8 
(1/26)
7.7
(3/39)
6.2 
(4/65)
ASD=c 2.38
MPX
9.1 
(8/88)
5.9 
(3/51)
7.9 
(11/139)
2.8 
(6/214)
2.9 
(3/105)
2.8 
(9/319)
ADHD=c 1.33
Total 
6.3 
(9/144)
7.0 
(9/129)
6.6 
(18/273)
2.9 
(7/240)
4.2 
(6/144)
3.4 
(13/384)
ASD=
ADHD
.51
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OR=1.52, 95 % CI 1.00–2.31, respectively. Children
from ASD families were almost four times more likely
to have suffered from a severe infection during pregnan-
cy and were one and a half times more likely to have
experienced at least one suboptimal condition at birth
than controls. These factors were not significantly asso-
ciated with ADHD. Further, a trend level effect of high
birth weight was found in ASD, χ2(1, N=668)=2.74,
p=0.098, OR=2.38, 95 % CI 0.85–6.63. Although
non-significant, high birth weight appeared to be more
frequent in ASD than controls, OR=2.38.
Predominantly associated with ADHD were the PPFs
low parental age, χ2 (1, N=878)=21.20, p<0.001,
OR=2.26, 95 % CI 1.60–3.21, tobacco use during preg-
nancy, χ2 (1, N=768)=7.87, p=0.005, OR=2.12, 95 % CI
1.52–4.48, and stress during pregnancy, χ2 (1, N=497)=
12.17, p<0.001, OR=2.61, 95 % CI 1.52–4.48. A nomi-
nally significant association was found between ADHD
and maternal diseases, χ2 (1, N=497)=5.67, p=0.017,
OR=1.84, 95 % CI 1.11–3.04. A reverse effect was found
for high parental age, χ2 (2, N=1168)=11.51, p=0.003,
with parents of ADHD cases being less likely to have an
advanced parental age than control parents, χ 2(1,
N=878)=10.85 p=0.001, OR=0.45, 95 % CI 0.28–0.72.
These results indicate that children from ADHD families
were over two times more likely to have young parents
than control children. Furthermore, case mothers were al-
most twice as likely to have suffered from at least one
disease and were over twice as likely to have smoked or
experienced stress during pregnancy as control mothers,
see Table 3 and Fig. 1. These factors were not significant-
ly associated with ASD. Moreover, the proportion of chil-
dren from ADHD families exposed to these four risk
factors was significantly higher than that of individuals
from ASD families, p-values<0.006.
PPFs Not Associated With ASD or ADHD
No differences in occurrence between ASD and ADHD cases
and controls were found for miscarriages/bleeding, alcohol
use during pregnancy, labor/parturition, prematurity, birth
weight, and fertility treatment, all p-values<0.10.
Comparing Significant PPFs in Affected and Unaffected
Siblings
As a next step, we compared affected vs. unaffected
siblings for their exposure to PPFs. We found that after
controlling for family size, ASD affected children were
more likely to be firstborn than their unaffected siblings,
χ2 (1, N=288)=8.77, p=0.003, OR=6.48, 95 % CI
1.88–22.33. A trend-level effect of being firstborn was
found for ADHD as well, χ2 (1, N=476) = 3.23,
p=0.072, OR=1.16, 95 % CI 0.99–1.35. A suboptimal
condition at birth was nominally significantly more fre-
quently reported in ASD-affected compared to ASD-
unaffected siblings, χ2 (1, N=287)=4.47, p=0.034,
OR=1.70, 95 % CI 1.04–2.79. ASD affected and unaf-
fected offspring did not significantly differ from each
other with regard to the prevalence of maternal infec-
tions, p=0.114. Within ADHD families, no significant
differences were found between ADHD-affected and un-
affected siblings for any of the identified PPFs,
p-values>0.10. However, despite suboptimal condition
at birth not being significantly associated with ADHD,
this perinatal complication was nominally significantly
Table 3 (continued)
10. 
Suboptimal 
condition
21.7 
(55/253)
SPX
35.7 
(20/56)
18.8
(15/80)
25.7 
(35/136)
46.7   
(7/15)
21.1   
(4/19)
32.4 
(11/34)
ASD>c 1.52
A>U 1.70 A>U 2.13 S<M .64 S=M 1.62MPX 35.4 
(34/96)
30.9 
(17/55)
33.8 
(51/151)
27.2 
(40/147)
15.9 
(10/63)
20.8 
(50/240)
ADHD=c 1.17
Total 
35.5 
(54/152)
23.7 
(32/135)
30.0 
(86/287)
29.0 
(47/162)
17.1 
(14/82)
25.0 
(61/244)
ASD=
ADHD
.77
11.  
Firstborn
49.8 
(203/408)
SPX
57.1 
(32/56)
27.2 
(22/81)
39.4 
(54/137)
54.8   
(17/31)
29.8 
(14/47)
39.7 
(31/78)
ASD<c 1.64
A>U 6.48 A>U 1.16 S>M .51 S>M .99MPX 45.8 
(44/96)
21.8
(12/55)
37.1 
(56/151)
45.6 
(123/270)
37.5 
(48/128)
43.0 
(171/398)
ADHD<c 1.41
Total 
50.0 
(76/152)
25.0 
(34/136)
38.2 
(110/288)
46.5 
(140/301)
35.4 
(62/175)
42.4 
(202/476)
ASD=
ADHD
.86
12. Fertility 
treatment
5.2 
(13/251)
SPX
7.1 
(4/56)
2.5 
(2/79)
4.4 
(6/135)
13.3   
(2/15)
0.0 
(0/19)
5.9 
(2/34)
ASD=c .89
MPX
7.3 
(7/96)
3.9 
(2/53)
6.0 
(9/149)
8.3 
(12/145)
6.3 
(4/63)
7.7 
(16/208)
ADHD=c 1.30
Total 
7.2 
(11/152)
3.0 
(4/132)
5.3 
(15/284)
8.8 
(14/160)
4.9 
(4/82)
7.4 
(18/242)
ASD=
ADHD
1.46
Note. ASD autism spectrum disorders; ADHD attention-deficit/hyperactivity disorder; SPX simplex;MPXmultiplex; PPFs pre- and perinatal risk factors; n number
of children with risk factor present; N total number of children within group; c controls; A affected siblings; U unaffected siblings; S individuals from simplex
families; M individuals from multiplex families; ♀ = mothers; ♂ = fathers, Contr contrasts, OR Odds ratio
Grey bars indicate the risk factors that are significantly associated with ASD and/or ADHD. The factor firstborn (in dark grey) was the only factor associated with
both disorders. *Significant contrasts are presented in bold, marginally significant findings in bold+ italic, trend level significant contrasts (p<0.10) are presented
in italic. # contrasts for mean family size
aTotal ASD families vs. total ADHD families vs. total control families
bCould not be calculated based on zero frequencies in cells
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more often reported in ADHD-affected compared to
ADHD-unaffected offspring, χ2 (1, N=244)=4.39,
p=0.036, OR=2.13, 95 % CI 1.05–4.33. Similarly,
s t ress during pregnancy was more frequent in
ASD-affected vs. ASD-unaffected children, χ2 (1,
N=286)=5.91, p=0.015, OR=2.19, 95 % CI 1.16–
4.13, see Fig. 2.
Comparing Significant PPFs in SPX Versus MPX
Families
A final step in the data analyses was the stratification
into SPX vs. MPX families. This revealed a trend-level
significant difference between SPX and MPX ASD fam-
ilies in the factor being firstborn, χ2 (1, N=288)=3.44,
p=0.064, OR=0.51, 95 % CI 0.24–1.04, with SPX
ASD families having proportionally more firstborns
than MPX ASD families. Further, trend-level effects
were found for SPX versus MPX ASD unaffected
siblings on suboptimal condition, χ2 (1, N=135)=5.91,
p=0.052, OR=0.44, 95 % CI 0.19–1.01, and for SPX
versus MPX ADHD siblings on being firstborn, χ2 (1,
N=175)=3.35, p=0.067, OR=0.51, 95 % CI 0.24–1.05.
Siblings from MPX families were more likely to be
firstborn (ADHD) or to have experienced a suboptimal
condition at birth (ASD) than unaffected siblings from
SPX families, see Fig. 2.
Discussion
This is the first study to test sharing and uniqueness of
the involvement of PPFs for ASD and ADHD, using an
approach that stratifies the sample into affected versus
unaffected offspring and SPX versus MPX affected fam-
ilies. In accordance with other studies, our findings in-
dicate that pre- and perinatal complications are more
frequent in children with ASD and ADHD compared
OR = 1.57 [95% CI: 0.28-8.64]
OR = 3.97 [95% CI: 1.00-15.82]
OR = 1.17 [95% CI: 0.75-1.84]
OR = 1.52 [95% CI: 1.00-2.31]
OR = 2.26 [95% CI: 1.60-3.21]
OR = 0.80 [95% CI: 0.52-1.23]
OR = 1.84 [95% CI: 1.11-3.04]
OR = 1.34 [95% CI: 0.79-2.25]
OR = 2.12 [95% CI: 1.26-3.58]
OR = 0.85 [95% CI: 0.42-1.70]
OR = 2.61 [95% CI: 1.52-4.48]
OR = 1.31 [95% CI: 0.76-2.27]
OR = 1.41 [95% CI: 1.24-1.61]
OR = 1.64 [95% CI: 1.37-1.97]
***
***
***
***
***
*
*
*
Fig. 1 Identified risk factors for individuals from ASD or ADHD
families. Note. ASD autism spectrum disorders; ADHD attention-deficit/
hyperactivity disorder.OR odds ratio. Represented are the odds that a risk
factor was present in children from ASD/ADHD families compared to
control children (reference line). Significant odd ratios are indicated with
an asterisk (*** p<0.001, * p<0.05)
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to control children. Novel findings are that we showed
that, except for large family size and more firstborns
amongst affected offspring, no shared PFFs were iden-
tified for ASD and ADHD. PPFs predominantly related
to ASD (maternal infections and suboptimal condition at
birth) were more often reported in affected offspring.
PPFs associated with ADHD (low parental age, maternal
diseases, maternal smoking and maternal stress) were
shared between affected and unaffected siblings.
Furthermore, by using the SPX-MPX stratification, we
showed that PPFs in ADHD appear to index an in-
creased shared familial risk, whereas in ASD PPFs pos-
sibly have a more determining role in the disorder.
This study adds importantly to the literature by demonstrating
that there are limited shared pre- and perinatal risk factors across
ADHD and ASD. This is surprising given that cross-disorder
traits were present in both ASD and ADHD affected and unaf-
fected siblings, mainly in MPX families (see sample character-
istics). Thismay suggest that the comorbid presence of ASD and
ADHD symptoms is not likely explained by shared pre-and
perinatal risk factors. The finding that affected siblings were
more often firstborns than unaffected siblings concurs with pre-
vious literature (Marin et al. 2012; Gardener et al. 2009). This
suggests that being firstborn may increase the risk for ASD and
ADHDalike, and possibly increase the risk for psychopathology
in general (Feehan et al. 1994). Other alternative (or additional)
explanations for the increased risk of developing ASD or
ADHD as a firstborn have also been suggested. For instance,
becoming a parent for the first time is life-changing and puts
high demands on parents. Parents are often more anxious and
restrictive with the first child than with later children (Eisenman
1992) and firstborn children (particularly boys) experience sig-
nificantly higher ineffective parenting behaviors as compared to
children without siblings or those with older siblings (Arim et al.
2012). Interestingly, family size was larger in families including
children with ASD or ADHD. Large family size has been
previously associated with ADHD (Biederman et al. 1995)
and has been linked to negative child outcomes such as lower
average educational levels (Booth and Hiau 2009). It is unclear
why case families appear to have more children than control
families. These differences in family size may reflect differences
in social economic status, religious beliefs, or impulsivity, but
this was not tested in this study.
Several PPFs were either predominantly associated with
ASD (maternal infections and suboptimal condition at birth)
or ADHD (low parental age, maternal diseases, smoking dur-
ing pregnancy, and stress during pregnancy). Higher frequen-
cies of maternal infections and suboptimal conditions at birth
in ASD cases are consistent with previous findings (Gardener
et al. 2011; Visser et al. 2013). These factors are likely to
reflect immune dysfunction and hypoxia, impacting on
neurodevelopment (Onore et al. 2012). Young maternal age
is a known risk factor for behavioral problems and has been
previously linked to ADHD (Gustafsson and Kallen 2011).
The finding that maternal smoking and stress during pregnan-
cy were significantly associatedwith ADHD also corroborates
with previous findings (Thapar et al. 2013). Some studies
have reported GxE interactions between some key ADHD risk
genes (DAT1, DRD4), maternal smoking (Neuman et al.
2007), and maternal stress (Grizenko et al. 2012), others did
not (Altink et al. 2009). Whether maternal smoking and stress
are causal agents or proxy variables for the genetic risk to
develop ADHD remains unclear (D’Onofrio et al. 2013).
The link between maternal tobacco use or maternal stress
and offspring ADHD might be attributable to transmission
of ADHD risk genes, in addition to any true environmentally
mediated effect (Thapar et al. 2013). Proposed mechanism
linking stress during pregnancy and ADHD include a disrup-
tion in stress-response systems and prefrontal cortex develop-
ment (Class et al. 2014). Last, maternal diseases such as ges-
tational diabetes mellitus (GDM) and preeclampsia have been
previously associated with ADHD (Nomura et al. 2012;
p =.003 p = .072 
p = .064 
p = .015 p = .034 p = .036 
Fig. 2 Comparisons between ASD and ADHD probands and their
unaffected siblings, stratified for SPX and MPX families. Note. ASD
autism spectrum disorders; ADHD attention-deficit/hyperactivity
disorder; SPX simplex; MPX multiplex. The interpolation lines
represent the percentage of control children with the risk factor present.
Dotted lines indicate trend-level significant findings
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Ornoy 2005). Maternal diseases might impact fetal brain
growth, possibly resulting in greater inattention and hyperac-
tivity (Ornoy 2005). Our study adds importantly to the
existing literature by showing that PPFs are relatively specific
for ASD and ADHD. These findings might suggest that the
strong overlap between the disorders is unlikely to be caused
by many overlapping pre- or perinatal risk factors.
More differentiation in the role of PPFs contributing to
ASD and ADHD was found when stratifying the sample into
affected versus unaffected children. In ADHD, all PPFs were
shared between affected and unaffected siblings. This corrob-
orates previous findings that some PPFs in ADHD (i.e., ma-
ternal smoking and alcohol use during pregnancy) did not
differ among affected and unaffected siblings (Ben Amor
et al. 2005). This was not the case in ASD. Here, PPFs were
more prevalent in autistic children compared to their unaffect-
ed siblings (Deykin and MacMahon 1980). This suggests that
PPFs in ASD may have a unique, highly penetrant contribu-
tion to the disorder and are more likely to be true determinants
(i.e., state factors), whereas in the case of ADHD, PPFs are
weak risk factors that only slightly increase the overall liability
for the disorder in a family (trait factors).
Further stratification into SPX andMPX families had some
additional value in understanding the role of PPFs, especially
for ASD. SPX andMPXASD families differed with respect to
birth order and suboptimal conditions at birth. In SPX ASD,
complications during childbirth were more frequent in affect-
ed children only, suggesting that these factors may explain
why that child did develop ASD, yet his/her siblings did not.
In MPX ASD however, a heightened incidence of suboptimal
birth conditions was shared between affected and unaffected
offspring. This may point to potential pre-perinatal etiological
differences between SPX and MPX forms of ASD.
Differences in birth rank effects between SPX and MPX
ASD families were previously examined, but the results were
opposite to ours (Turner et al. 2011), with middle children
(particularly those born second) having a higher risk of devel-
oping autism than other children inMPX families and increas-
ing risk with each additional birth in SPX families. It was
argued that the latter finding might be explained by a higher
number of (possibly causative) de novo mutations due to in-
creasing parental age. It is a challenge to explain our finding
that SPX affected offspring was more often firstborn than
unaffected offspring. Possibly, gene x environment interac-
tions and purely environmental mechanisms for the develop-
ment of ASD are different for the two types of ASD families.
SPX and MPX ADHD could not be significantly dissociated
from each other regarding PPFs. These results suggest that
SPX-MPX stratification is more suitable to differentiate ef-
fects of PPF in ASD families, but in its current form provided
little further insight in the role of PPFs in ADHD. However,
the limited sample sizes of SPX ADHD families in combina-
tion with the low exposure rates for some of the PPFs resulted
in a lack of power to detect effects of small size. Based on
these non-significant but small effects (OR>1.5), some risk
factors appear to be more frequently shared by affected and
unaffected siblings from MPX than SPX ADHD, e.g., mater-
nal diseases, stress during pregnancy and suboptimal birth
conditions. Surely, more research is needed to confirm this
hypothesis.
Of note, no evidence was found for the association of low
birth weight with ASD or ADHD, which was the most prom-
ising common risk factor based on previous reports (Ben
Amor et al. 2005; Gardener et al. 2011). A possible explana-
tion might be that low birth weight is often associated with
advancedmaternal and paternal age (Shah et al. 2010), and the
proportion of mothers older than 35 years at conception was
significantly smaller in case mothers than in control mothers
in our study. We could not replicate the consistently reported
finding of advanced parental age being associated with ASD
in our sample (Gardener et al. 2009). Also, no support was
found for maternal smoking being a shared PPF for ASD and
ADHD. Previous studies reported that maternal smoking
might be specifically related to PDD-NOS, but not
(childhood) autistic disorder or Asperger’s syndrome (Visser
et al. 2013). In our sample, we did not examine subgroups
within ASD, which might have diluted the effect.
Alternatively, among the ASDs, PDD-NOS is the most diffi-
cult subtype to distinguish from ADHD, and maternal
smoking may actually be a unique (genetically driven) PPF
for ADHD (Jaspers et al. 2013).
A number of limitations of this study should be considered
when weighing the results. First, this study should be viewed
as a first step towards a better understanding of the unique and
shared contribution of PPFs to the development of sporadic or
common ASD and/or ADHD. However, the combination of
limited sample sizes of SPX ADHD families in combination
with the low exposure rates and interdependence for some of
the PPFs resulted in decreased power to detect some true
group differences. Therefore, our results should be interpreted
with caution. A large majority of ADHD cases stem from
MPX families, SPX ADHD families seem to be a relatively
rare phenomenon in itself (15.3 % in our sample). Strategic
oversampling of SPX ADHD families might be necessary to
increase the power of studies using the SPX-MPX stratifica-
tion. A second important limitation is that our study design
was not suited to test causal inference, thus caution is required
in assuming that PPFs have causal effects on ASD and
ADHD. As Thapar and Rutter (2009) pointed out previously,
significant associations between pre/perinatal risk factors and
psychiatric disorders may arise because of postnatal risks
(e.g., parent mental health problems, social adversity) or
through unmeasured confounders including maternally trans-
mitted inherited factors (Thapar and Rutter 2009). Therefore,
additional studies indeed using natural experiments such as in
Rice et al. (2010) and Thapar et al. (2009), even though highly
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difficult to undertake, are needed to further test whether the
identified PFFs are true causal factors for ASD and ADHD.
We feel that our study nonetheless adds to the current literature
because to our knowledge, this is the first study that ex-
amined (a) overlapping PFFs for ASD and ADHD, and
(b) whether risk factors are shared or non-shared between
affected and unaffected siblings which may lead to impor-
tant conclusions about the role of a risk factor in the
development of a disorder. Third, the pre-/perinatal data
was collected retrospectively which could have resulted in
a recall bias when comparing cases to controls. However,
previous research shows a reasonable agreement between
parent report and medical records for most birth-related
data (Buka et al. 2004), and it is unlikely to explain our
main finding of PPFs being rather specific for ASD and
ADHD. Fourth, because a shorter form of the question-
naire was administered in about half of the ADHD fami-
lies, small numbers of individuals were available for some
of the exposures. However, we believe that insofar this
has affected our results, it would likely lead to underesti-
mation of the effect of pre-and perinatal complications on
ADHD since we identified significant associations be-
tween ADHD and four PPFs. Fifth, the comorbidity of
ASD in ADHD families and vice versa, ADHD in ASD
families was high. We believe that insofar that this would
have affected our results, this would have biased the re-
sults towards finding many shared PPFs and not towards
finding no or limited shared PPFs, which was not what we
found. Therefore, we believe that we can maintain our
statement that the high co-morbidity is not likely to be
explained by shared PPFs. Last, boys were overrepresent-
ed in the clinical samples compared to the control cohort
and previous studies report that pre/perinatal complica-
tions are more prevalent in boys (Lukkari et al. 2012).
Therefore we controlled for sex in our analyses.
In conclusion, the findings reported here indicate that pre-
and perinatal complications are more frequent in children with
ASD and ADHD compared to control children. Most of the
PPFs were uniquely related to either ASD or ADHD, suggest-
ing that the high co-morbidity is not likely to be explained by
shared pre-and perinatal risk factors. Instead, PPFs might play
a crucial role in the developmental pathways discriminating
the disorders on a background of shared genetic factors.
Further stratification into affected versus unaffected siblings
suggests that PPFs in ASD may have a unique, highly pene-
trant contribution to the disorder and are more likely to be true
determinants (i.e., state factors), whereas in the case of
ADHD, PPFs are weak risk factors that only slightly increase
the overall liability for the disorder in a family (trait factors).
In agreement with our hypothesis, some PPFs appeared to be
more frequently shared by affected and unaffected siblings
from MPX than SPX families, particularly in ASD. This
may pinpoint to potential pre-perinatal etiological differences
between SPX and MPX forms of the disorder. These results
can stimulate further research on the complex etiologies of
ASD and ADHD and the role of PPFs herein.
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